{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:57:45Z","timestamp":1781067465439,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    House dust mite (HDM) allergy contributes to allergic rhinitis and asthma worldwide. Allergen-specific immunotherapy (AIT) is the only disease-modifying treatment, with immunoglobulin G4 (IgG4) and regulatory T cells (Tregs) mediating immune tolerance. Comparative immunological effects of subcutaneous (SCIT) versus sublingual (SLIT) therapy remain underexplored. To evaluate immunological changes induced by SCIT and SLIT and their association with clinical improvement in HDM-allergic patients. In this prospective cohort, 43 adults with HDM-sensitized allergic patients received SCIT (n\u2009=\u200922) or SLIT (n\u2009=\u200921) for nine months. Clinical outcomes were assessed using the Asthma Control Test (ACT) and Rhinitis Control Assessment Test (RCAT). Serum IgG4 and total IgE were measured by ELISA and electrochemiluminescence, respectively, and CD4\u207aCD25\u207aFoxP3\u207a Tregs were analyzed by flow cytometry. Responders were defined as patients achieving\u2009\u2265\u200920% improvement in ACT or RCAT. Wilcoxon signed-rank, Mann\u2013Whitney U, and Spearman correlation tests were used. AIT increased IgG4 (320\u2009\u2192\u2009920 ng\/mL;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and Tregs (3.4%\u2009\u2192\u20096.3%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), with a non-significant decrease in IgE. Responders had higher IgG4 and Tregs and lower IgE than non-responders. SCIT elicited higher IgG4 levels (median 1035 vs 705\u00a0ng\/mL) and a trend toward greater Treg expansion compared with SLIT, although clinical improvement was similar between groups. IgG4 correlated with ACT (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and RCAT (p\u2009=\u20090.002), and Tregs correlated positively with IgG4 (p\u2009=\u20090.003) and inversely with IgE (p\u2009=\u20090.010). Both SCIT and SLIT improve clinical outcomes in HDM-allergic patients via total IgG4 elevation and Treg expansion. SCIT may induce stronger systemic immunological responses, supporting the use of these biomarkers for early monitoring and personalized therapy. These findings should be interpreted within the context of a pilot study with a relatively small sample size.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-56260-8","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:46:09Z","timestamp":1781019969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunological effects of subcutaneous and sublingual immunotherapy in house dust mite-allergic adults: a nine-month prospective pilot study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8224-8701","authenticated-orcid":false,"given":"Sara I.","family":"Taha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Tollah","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf Abdelalim","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Ghonaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamyaa","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"56260_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186301","volume":"14","author":"BH Cheng","year":"2023","unstructured":"Cheng, B. H., Xiao, X., Jin, Y. & Li, J. Editorial: Mechanisms and advances in respiratory allergic diseases. Front. Immunol. 14, 1186301. https:\/\/doi.org\/10.3389\/fimmu.2023.1186301 (2023).","journal-title":"Front. Immunol."},{"key":"56260_CR2","doi-asserted-by":"publisher","unstructured":"Shin, Y. H., Hwang, J., Kwon, R., Lee, S. W., Kim, M. S; GBD 2019 Allergic Disorders Collaborators; Shin, J. I., Yon, D. K. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the global burden of disease study 2019. Allergy. 78(8):2232-2254. https:\/\/doi.org\/10.1111\/all.15807 (2023).","DOI":"10.1111\/all.15807"},{"issue":"6","key":"56260_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-016-0622-9","volume":"16","author":"A Pom\u00e9s","year":"2016","unstructured":"Pom\u00e9s, A., Chapman, M. D. & W\u00fcnschmann, S. Indoor allergens and allergic respiratory disease. Curr. Allergy Asthma Rep. 16(6), 43. https:\/\/doi.org\/10.1007\/s11882-016-0622-9 (2016).","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"10","key":"56260_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.molmed.2011.05.014","volume":"17","author":"A Jacquet","year":"2011","unstructured":"Jacquet, A. The role of innate immunity activation in house dust mite allergy. Trends Mol. Med. 17(10), 604\u2013611. https:\/\/doi.org\/10.1016\/j.molmed.2011.05.014 (2011).","journal-title":"Trends Mol. Med."},{"issue":"12","key":"56260_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125660","volume":"26","author":"K Jurkiewicz","year":"2025","unstructured":"Jurkiewicz, K., Jutel, M. & Smolinska, S. Update on HDM allergy: Principal changes over the years. Int. J. Mol. Sci. 26(12), 5660. https:\/\/doi.org\/10.3390\/ijms26125660 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"56260_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.alit.2020.08.002","volume":"69","author":"UC Kucuksezer","year":"2020","unstructured":"Kucuksezer, U. C. et al. Mechanisms of allergen-specific immunotherapy and allergen tolerance. Allergol. Int. 69(4), 549\u2013560. https:\/\/doi.org\/10.1016\/j.alit.2020.08.002 (2020).","journal-title":"Allergol. Int."},{"issue":"2","key":"56260_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020212","volume":"11","author":"GF Pav\u00f3n-Romero","year":"2022","unstructured":"Pav\u00f3n-Romero, G. F. et al. Allergen immunotherapy: Current and future trends. Cells 11(2), 212. https:\/\/doi.org\/10.3390\/cells11020212 (2022).","journal-title":"Cells"},{"issue":"2","key":"56260_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.anai.2016.06.027","volume":"117","author":"MG Lawrence","year":"2016","unstructured":"Lawrence, M. G., Steinke, J. W. & Borish, L. Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy. Ann. Allergy Asthma Immunol. 117(2), 138\u2013142. https:\/\/doi.org\/10.1016\/j.anai.2016.06.027 (2016).","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"5","key":"56260_CR9","first-page":"148","volume":"4","author":"CE Olivier","year":"2013","unstructured":"Olivier, C. E., Lima, R. P., Argent\u00e3o, D. G., Silva, M. S. R. & Pensuti, M. Group-specific multi-allergen sublingual\/swallow immunotherapy improves the quality of life of polysensitized children and adults with allergic rhinitis. J. Allergy Ther. 4(5), 148 (2013).","journal-title":"J. Allergy Ther."},{"issue":"5","key":"56260_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13050845","volume":"13","author":"UM Sahiner","year":"2023","unstructured":"Sahiner, U. M. et al. Mechanisms of allergen immunotherapy and potential biomarkers for clinical evaluation. J. Pers. Med. 13(5), 845. https:\/\/doi.org\/10.3390\/jpm13050845 (2023).","journal-title":"J. Pers. Med."},{"issue":"9","key":"56260_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells14090639","volume":"14","author":"LL Shi","year":"2025","unstructured":"Shi, L. L. et al. Role of IgG4 antibodies in human health and disease. Cells 14(9), 639. https:\/\/doi.org\/10.3390\/cells14090639 (2025).","journal-title":"Cells"},{"issue":"9","key":"56260_CR12","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1136\/gutjnl-2025-335375","volume":"74","author":"I Piseddu","year":"2025","unstructured":"Piseddu, I., Mayerle, J., Mahajan, U. M. & Boehmer, D. F. R. The dual role of IgG4 in immunity: Bridging pathophysiology and therapeutic applications. Gut 74(9), 1528\u20131538. https:\/\/doi.org\/10.1136\/gutjnl-2025-335375 (2025).","journal-title":"Gut"},{"key":"56260_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1387975","volume":"15","author":"Y Zong","year":"2024","unstructured":"Zong, Y., Deng, K. & Chong, W. P. Regulation of Treg cells by cytokine signaling and co-stimulatory molecules. Front. Immunol. 15, 1387975. https:\/\/doi.org\/10.3389\/fimmu.2024.1387975 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"56260_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02326-4","volume":"10","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. Regulatory T cells in homeostasis and disease: Molecular mechanisms and therapeutic potential. Signal Transduct. Target. Ther. 10(1), 345. https:\/\/doi.org\/10.1038\/s41392-025-02326-4 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1 Suppl","key":"56260_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","volume":"127","author":"L Cox","year":"2011","unstructured":"Cox, L. et al. Allergen immunotherapy: A practice parameter third update. J. Allergy Clin. Immunol. 127(1 Suppl), S1-55. https:\/\/doi.org\/10.1016\/j.jaci.2010.09.034 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56260_CR16","unstructured":"Dubin S, Patak P, Jung D. 2024 Update on Asthma Management Guidelines. Mo Med. 121(5):364\u2013367."},{"key":"56260_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/all.70131","author":"B Sousa-Pinto","year":"2025","unstructured":"Sousa-Pinto, B. et al. Allergic rhinitis and its impact on asthma (ARIA)-EAACI guidelines-2024-2025 revision: Part I-Guidelines on intranasal treatments. Allergy https:\/\/doi.org\/10.1111\/all.70131 (2025).","journal-title":"Allergy"},{"issue":"4","key":"56260_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/0009922816675013","volume":"56","author":"N du Rivage","year":"2017","unstructured":"du Rivage, N. et al. Asthma control test. Clin. Pediatr. 56(4), 341\u2013347. https:\/\/doi.org\/10.1177\/0009922816675013 (2017).","journal-title":"Clin. Pediatr."},{"issue":"1","key":"56260_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/ACI.0000000000000020","volume":"14","author":"RA Nathan","year":"2014","unstructured":"Nathan, R. A. The rhinitis control assessment test: Implications for the present and future. Curr. Opin. Allergy Clin. Immunol. 14(1), 13\u201319. https:\/\/doi.org\/10.1097\/ACI.0000000000000020 (2014).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"1","key":"56260_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-3-3","volume":"3","author":"L Heinzerling","year":"2013","unstructured":"Heinzerling, L. et al. The skin prick test\u2014European standards. Clin. Transl. Allergy 3(1), 3. https:\/\/doi.org\/10.1186\/2045-7022-3-3 (2013).","journal-title":"Clin. Transl. Allergy"},{"key":"56260_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603050","volume":"11","author":"C Kanagaratham","year":"2020","unstructured":"Kanagaratham, C., El Ansari, Y. S., Lewis, O. L. & Oettgen, H. C. IgE and IgG antibodies as regulators of mast cell and basophil functions in food allergy. Front. Immunol. 11, 603050. https:\/\/doi.org\/10.3389\/fimmu.2020.603050 (2020).","journal-title":"Front. Immunol."},{"issue":"5","key":"56260_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaci.2023.01.005","volume":"151","author":"MR Strobl","year":"2023","unstructured":"Strobl, M. R. et al. The role of IgG1 and IgG4 as dominant IgE-blocking antibodies shifts during allergen immunotherapy. J. Allergy Clin. Immunol. 151(5), 1371-1378.e5. https:\/\/doi.org\/10.1016\/j.jaci.2023.01.005 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56260_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.892631","volume":"13","author":"S Zinkhan","year":"2022","unstructured":"Zinkhan, S., Thoms, F., Augusto, G., Vogel, M. & Bachmann, M. F. On the role of allergen-specific IgG subclasses for blocking human basophil activation. Front. Immunol. 13, 892631. https:\/\/doi.org\/10.3389\/fimmu.2022.892631 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"56260_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40413-015-0063-2","volume":"8","author":"CA Akdis","year":"2015","unstructured":"Akdis, C. A. & Akdis, M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ. J. 8(1), 17. https:\/\/doi.org\/10.1186\/s40413-015-0063-2 (2015).","journal-title":"World Allergy Organ. J."},{"key":"56260_CR25","doi-asserted-by":"publisher","first-page":"1242860","DOI":"10.3389\/fimmu.2023.1242860","volume":"14","author":"JR Victor","year":"2023","unstructured":"Victor, J. R. & Nahm, D. H. Mechanism underlying polyvalent IgG-induced regulatory T cell activation and its clinical application: Anti-idiotypic regulatory T cell theory for immune tolerance. Front. Immunol. 14, 1242860. https:\/\/doi.org\/10.3389\/fimmu.2023.1242860 (2023).","journal-title":"Front. Immunol."},{"issue":"6","key":"56260_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1398-9995.2011.02589.x","volume":"66","author":"M Jutel","year":"2011","unstructured":"Jutel, M. & Akdis, C. A. Immunological mechanisms of allergen-specific immunotherapy. Allergy 66(6), 725\u2013732. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02589.x (2011).","journal-title":"Allergy"},{"issue":"11","key":"56260_CR27","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1172\/JCI78891","volume":"124","author":"CA Akdis","year":"2014","unstructured":"Akdis, C. A. & Akdis, M. Mechanisms of immune tolerance to allergens: Role of IL-10 and Tregs. J. Clin. Invest. 124(11), 4678\u20134680. https:\/\/doi.org\/10.1172\/JCI78891 (2014).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"56260_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/intimm\/dxae042","volume":"37","author":"S Yamazaki","year":"2024","unstructured":"Yamazaki, S. Diverse roles of dendritic cell and regulatory T cell crosstalk in controlling health and disease. Int. Immunol. 37(1), 5\u201314. https:\/\/doi.org\/10.1093\/intimm\/dxae042 (2024).","journal-title":"Int. Immunol."},{"key":"56260_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.633436","volume":"12","author":"S Ness","year":"2021","unstructured":"Ness, S., Lin, S. & Gordon, J. R. Regulatory dendritic cells, T Cell tolerance, and dendritic cell therapy for immunologic disease. Front. Immunol. 12, 633436. https:\/\/doi.org\/10.3389\/fimmu.2021.633436 (2021).","journal-title":"Front. Immunol."},{"key":"56260_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s44337-024-00029-3","volume":"1","author":"Y Sharma","year":"2024","unstructured":"Sharma, Y., Arora, M. & Bala, K. The potential of immunomodulators in shaping the future of healthcare. Discov. Med. 1, 37. https:\/\/doi.org\/10.1007\/s44337-024-00029-3 (2024).","journal-title":"Discov. Med."},{"issue":"5","key":"56260_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00011-021-01460-3","volume":"70","author":"T Terada","year":"2021","unstructured":"Terada, T. et al. Sublingual immunotherapy for 4 years increased the number of Foxp3+ Treg cells, which correlated with clinical effects. Inflamm. Res. 70(5), 581\u2013589. https:\/\/doi.org\/10.1007\/s00011-021-01460-3 (2021).","journal-title":"Inflamm. Res."},{"key":"56260_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/492405","volume":"2012","author":"D Saporta","year":"2012","unstructured":"Saporta, D. Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients. J. Environ. Public Health 2012, 492405. https:\/\/doi.org\/10.1155\/2012\/492405 (2012).","journal-title":"J. Environ. Public Health"},{"issue":"3","key":"56260_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jaci.2014.07.024","volume":"134","author":"CS Bauer","year":"2014","unstructured":"Bauer, C. S. & Rank, M. A. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy. J. Allergy Clin. Immunol. 134(3), 765-765.e2. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.024 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56260_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1274241","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang, J. & Lei, S. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: A systematic review and meta-analysis. Front. Immunol. 14, 1274241. https:\/\/doi.org\/10.3389\/fimmu.2023.1274241 (2023).","journal-title":"Front. Immunol."},{"issue":"6","key":"56260_CR35","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3349\/ymj.2016.57.6.1427","volume":"57","author":"KH Park","year":"2016","unstructured":"Park, K. H. et al. Different responses in induction of allergen specific immunoglobulin G4 and IgE-blocking factors for three mite subcutaneous immunotherapy products. Yonsei Med. J. 57(6), 1427\u20131434. https:\/\/doi.org\/10.3349\/ymj.2016.57.6.1427 (2016).","journal-title":"Yonsei Med. J."},{"issue":"4","key":"56260_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antib10040049","volume":"10","author":"G Nikolov","year":"2021","unstructured":"Nikolov, G. et al. Allergen-specific IgE and IgG4 as biomarkers for immunologic changes during subcutaneous allergen immunotherapy. Antibodies 10(4), 49. https:\/\/doi.org\/10.3390\/antib10040049 (2021).","journal-title":"Antibodies"},{"issue":"2","key":"56260_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaci.2021.12.262","volume":"149","author":"A Devine","year":"2022","unstructured":"Devine, A. et al. Induction of allergen-neutralizing IgG4 and IgA blocking antibodies following subcutaneous immunotherapy with Mannan-Conjugated Birch Pollen Allergoid. J. Allergy Clin. Immunol. 149(2), 72 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"56260_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltac022","volume":"2","author":"RS Rahman","year":"2022","unstructured":"Rahman, R. S. & Wesemann, D. R. Immunology of allergen immunotherapy. Immunother. Adv. 2(1), ltac022. https:\/\/doi.org\/10.1093\/immadv\/ltac022 (2022).","journal-title":"Immunother. Adv."},{"issue":"6","key":"56260_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.4161\/hv.28592","volume":"10","author":"S Chirumbolo","year":"2014","unstructured":"Chirumbolo, S. Immunotherapy in allergy and cellular tests: State of art. Hum. Vaccin. Immunother. 10(6), 1595\u20131610. https:\/\/doi.org\/10.4161\/hv.28592 (2014).","journal-title":"Hum. Vaccin. Immunother."},{"issue":"5","key":"56260_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.amjms.2019.02.004","volume":"357","author":"MR Chaaban","year":"2019","unstructured":"Chaaban, M. R., Mansi, A., Tripple, J. W. & Wise, S. K. SCIT versus SLIT: Which one do you recommend, Doc?. Am. J. Med. Sci. 357(5), 442\u2013447. https:\/\/doi.org\/10.1016\/j.amjms.2019.02.004 (2019).","journal-title":"Am. J. Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56260-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56260-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56260-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:07:52Z","timestamp":1781064472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56260-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56260"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56260-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was approved by the Medical Research Ethical Committee, Faculty of Medicine, Ain Shams University (Approval No. FMASU MS 665\/2023). Written informed consent was obtained from all participants prior to inclusion, in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17865"}}